Sort
48,018 grants matching “immunotherapy”
The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy
$407,530Benjamin Izar · Columbia University Health Sciences · R01 · FY2022 · CA
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant
$407,503Jarrod Dudakov · Fred Hutchinson Cancer Center · R01 · FY2022 · HL
Beta glucan enhances antibody therapy for neuroblastoma
$407,500Sloan-Kettering Institute For Cancer Res · R21 · FY2002 · CA
Beta glucan enhances antibody therapy for neuroblastoma
$407,500Sloan-Kettering Institute For Cancer Res · R21 · FY2003 · CA
Cold-responsive gene and drug delivery-potentiated cryoimmunotherapy
$407,483Wenquan Ou · Univ Of Maryland, College Park · R01 · FY2025 · CA
Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$407,472Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · AI
High Resolution Functional Maps of Enhancer RNA and Subcellular RNA Granules in Human Immune Cells
$407,440Hojoong Kwak · New York Medical College · R35 · FY2025 · GM
Preventing follicular lymphoma progression and transformation through precision therapy
$407,355Wendy Beguelin · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Role of Staphylococcus aureus alpha-hemolysin in disease
$407,340Juliane Bubeck Wardenburg · Washington University · R01 · FY2019 · AI
Predicting the Likelihood of Immune-related Adverse Events in Breast Cancer Patients
$407,338Amrita Basu Somani · University Of California, San Francisco · R21 · FY2021 · CA
Dissecting the Sox2-orchestrated transcriptional network that governs immune resistance in tumor initiating cells
$407,298Yuxuan Phoenix Miao · University Of Chicago · R01 · FY2024 · CA
Dissecting the Sox2-orchestrated transcriptional network that governs immune resistance in tumor initiating cells
$407,298Yuxuan Phoenix Miao · University Of Chicago · R01 · FY2025 · CA
Advancing the Coordinating Center for the Canine Cancer Immunotherapy Network
$407,282Nicola J Mason · University Of Pennsylvania · U24 · FY2023 · CA
Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment
$407,268Jenny J Yang · Georgia State University · R33 · FY2019 · CA
IN VITRO STUDIES OF HUMAN ANAPHYLAXIS
$407,263Johns Hopkins University · R01 · FY2000 · AI
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$407,228Xiang Zhang · Baylor College Of Medicine · R01 · FY2022 · CA
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$407,228Xiang Zhang · Baylor College Of Medicine · R01 · FY2023 · CA
Collagen Binding MSCRAMMs
$407,199Texas A&M University Health Science Ctr · R01 · FY2002 · AR
Improving Patient Adherence to Cancer Treatment
$407,197University Of Southern California · R01 · FY2001 · CA
eDyNAmiC - SCRIPPS
$407,188Benjamin F Cravatt · Scripps Research Institute, The · OT2 · FY2025 · CA
Single-cell and imaging data integration software to spatially resolve the tumor microenvironment
$407,184Elana Fertig · Johns Hopkins University · U01 · FY2021 · CA
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
$407,175Thanh Uyen Barbie · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$407,175Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$407,175Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
$407,175Thanh Uyen Barbie · Dana-Farber Cancer Inst · R01 · FY2022 · CA